These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2858076)

  • 1. Tolerance to the behavioral actions of benzodiazepines.
    File SE
    Neurosci Biobehav Rev; 1985; 9(1):113-21. PubMed ID: 2858076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex.
    Ferreri MC; Gutiérrez ML; Gravielle MC
    Neuroscience; 2015 Dec; 310():152-62. PubMed ID: 26391922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepines and the developing rat: a critical review.
    Tucker JC
    Neurosci Biobehav Rev; 1985; 9(1):101-11. PubMed ID: 2858075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural pharmacology of benzodiazepines.
    File SE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):19-31. PubMed ID: 6145185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral neurochemistry of benzodiazepines.
    Stein L
    Arzneimittelforschung; 1980; 30(5a):868-73. PubMed ID: 6106487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs.
    Hutchinson MA; Smith PF; Darlington CL
    Prog Neurobiol; 1996 May; 49(1):73-97. PubMed ID: 8817699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to the anticonvulsant action of benzodiazepines. Relationship to decreased receptor density.
    Rosenberg HC; Tietz EI; Chiu TH
    Neuropharmacology; 1985 Jul; 24(7):639-44. PubMed ID: 2862604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action.
    Shephard RA
    Life Sci; 1987 Jun; 40(25):2429-36. PubMed ID: 2884549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of cross-tolerance in mice between the stimulatory and depressant actions of novel anxiolytics in the holeboard.
    Pellow S; File SE
    Behav Brain Res; 1987 Feb; 23(2):159-66. PubMed ID: 2882763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
    Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM
    Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to midazolam's anxiolytic effects after short-term nicotine treatment.
    Irvine EE; Cheeta S; Lovelock C; File SE
    Neuropharmacology; 2001 Apr; 40(5):710-6. PubMed ID: 11311899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
    File SE; Pellow S
    Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA and the behavioral effects of anxiolytic drugs.
    Sanger DJ
    Life Sci; 1985 Apr; 36(16):1503-13. PubMed ID: 2858804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the behavioral, neurophysiological, and motor effects of psychotropic drugs in the dog.
    Bruhwyler J; Chleide E
    Biol Psychiatry; 1990 Jun; 27(11):1264-78. PubMed ID: 1972339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
    Kralic JE; O'Buckley TK; Khisti RT; Hodge CW; Homanics GE; Morrow AL
    Neuropharmacology; 2002 Sep; 43(4):685-94. PubMed ID: 12367614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327.
    Wada T; Nakajima R; Kurihara E; Narumi S; Masuoka Y; Goto G; Saji Y; Fukuda N
    Jpn J Pharmacol; 1989 Mar; 49(3):337-49. PubMed ID: 2568511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
    De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
    Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the development of tolerance to various benzodiazepines.
    Nowakowska E; Chodera A; Cenajek-Musiał D; Szczawińska K
    Pol J Pharmacol Pharm; 1987; 39(3):245-52. PubMed ID: 2894019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
    De Sarro G; Di Paola ED; Aguglia U; de Sarro A
    Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.